PARP-1 Inhibition Increases Mitochondrial Metabolism through SIRT1 Activation-Reference-Cited by-同舟云学术

PARP-1 Inhibition Increases Mitochondrial Metabolism through SIRT1 Activation

Published:2011-04 Issue:4 Volume:13 Page:461-468
ISSN:1550-4131
Container-title:Cell Metabolism
language:en
Short-container-title:Cell Metabolism

Author:

Bai Péter,Cantó Carles,Oudart Hugues,Brunyánszki Attila,Cen Yana,Thomas Charles,Yamamoto Hiroyasu,Huber Aline,Kiss Borbála,Houtkooper Riekelt H.,Schoonjans Kristina,Schreiber Valérie,Sauve Anthony A.,Menissier-de Murcia Josiane,Auwerx Johan

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Physiology

Reference28 articles.

1. Poly(ADP-ribose) synthase is the major endogenous nonhistone acceptor for poly(ADP-ribose) in alkylated rat hepatoma cells;Adamietz;Eur. J. Biochem.,1987

2. A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis;Ahn;Proc. Natl. Acad. Sci. USA,2008

3. Regulation of SIRT 1 mediated NAD dependent deacetylation: a novel role for the multifunctional enzyme CD38;Aksoy;Biochem. Biophys. Res. Commun.,2006

4. Poly(ADP-ribose) polymerase in base excision repair: always engaged, but not essential for DNA damage processing;Allinson;Acta Biochim. Pol.,2003

5. Poly(ADP-ribose) polymerase 1 participates in the phase entrainment of circadian clocks to feeding;Asher;Cell,2010

Cited by 680 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of nonesterified fatty acids in cancer biology: Focus on tryptophan and related metabolism;Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids;2024-10

2. SIRT1 Regulates Mitochondrial Damage in N2a Cells Treated with the Prion Protein Fragment 106–126 via PGC-1α-TFAM-Mediated Mitochondrial Biogenesis;International Journal of Molecular Sciences;2024-09-07

3. Oxidative stress and PARP activation in the lungs is an early event in COVID-19 pneumonia;2024-09-04

4. Tankyrase1/2 inhibitor XAV-939 reverts EMT and suggests that PARylation partially regulates aerobic activities in human hepatocytes and HepG2 cells;Biochemical Pharmacology;2024-09

5. NAD+ metabolism and therapeutic strategies in cardiovascular diseases;Atherosclerosis Plus;2024-09